Does Rallies show 13F holders for AVNS?

Yes. Rallies tracks hedge fund and 13F ownership data for AVNS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AVNS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.

AVNS (Avanos Medical, Inc.) Stock Analysis - Hedge Fund Holdings

Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AVNS stock?

Hedge funds tracked by Rallies that own AVNS include Panagora Asset, Maverick Capital, and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avanos Medical, Inc..

AVNS Key Metrics

Key financial metrics for AVNS
Metric	Value
Price	$24.74
Market Cap	$1.16B
P/E Ratio	-2.90
EPS	$-8.53
Dividend Yield	0.00%
52-Week High	$24.91
52-Week Low	$9.30
Volume	0
Avg Volume	0
Revenue (TTM)	$687.80M
Net Income	$-392.10M
Gross Margin	55.44%

Top Hedge Funds Holding AVNS

Panagora Asset holds 48.23K shares of AVNS, changed -0.02% as of Dec 31, 2025.
Maverick Capital holds 16.90K shares of AVNS, changed +67.46% as of Mar 31, 2024.
Bridgewater Associates holds 10.47K shares of AVNS, changed -35.10% as of Sep 30, 2024.

Latest AVNS News

Avanos Medical Agrees to $1.272B Buyout, Q1 Sales Rise 8.8% — May 5, 2026
Avanos Medical $25 Cash Sale Spurs Legal Probe Over Potential Fiduciary Breaches — Apr 23, 2026
Avanos Medical’s Q4 EPS Tops Estimate by 20.8%, Shares Slide 10% — Feb 25, 2026
Avanos Medical 2025 Sales Climb 1.9% to $701M, Plans $20M Cost Savings — Feb 24, 2026

Recent AVNS Insider Trades

Holbrook Kerr sold 13.83K (~$152.17K) on Nov 18, 2025.
Holbrook Kerr sold 100 (~$1.10K) on Nov 18, 2025.
Holbrook Kerr sold 761 (~$8.38K) on Nov 18, 2025.

AVNS Analyst Consensus

AVNS analyst coverage data. Average price target: $0.00.

Common questions about AVNS

Who owns AVNS stock?: Hedge funds tracked by Rallies that own AVNS include Panagora Asset, Maverick Capital, and Bridgewater Associates. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Avanos Medical, Inc..
Does Rallies show 13F holders for AVNS?: Yes. Rallies tracks hedge fund and 13F ownership data for AVNS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AVNS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.